Newly published data confirm that daily topical tirbanibulin (Klisyri) was effective at treating actinic keratosis lesions on the face and scalp in two phase III trials. In two identical double-blind ... Healio: FDA expands Klisyri approval for actinic keratosis treatment on larger face, scalp areas FDA expands Klisyri approval for actinic keratosis treatment on larger face, scalp areas Tirbanibulin ointment 1% shows good safety and tolerability in the treatment of actinic keratosis (AK) in fields of up to 100 cm 2 on the face and scalp.

Understanding the Context

The most common local effects of treatment ... Nasdaq: Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp MedPage Today: Want Data on Recently Approved Actinic Keratosis Drug? Here You Go Today: Do you have dry skin that never gets better? It could be actinic keratosis